We serve patients from Kernersville NC, Colfax NC, Walkertown NC, Oak Ridge NC, Wallburg NC, Belews Creek NC, Winston-Salem NC, and surrounding areas
Blue Cross Blue Shield of Michigan will no longer cover GLP-1s to treat obesity starting January 2025
The association was still present when patients on medications for opioid, alcohol, or nicotine use disorder were excluded, with a 44% lower risk during active GLP-1 use and a 28% lower risk after discontinuation
In an analysis published in JAMA Network Open, GLP-1 receptor agonist use was associated with improved survival and recurrence outcomes in women with breast cancer who also had obesity or type 2 diabetes
The decision to use compounded drugs is guided by the licensed provider's medical judgment, which is informed by a Telehealth consultation and medical history